References
- Kannel WB, Doyle JT, Ostfeld AM, et al. Optimal resources for primary prevention of atherosclerotic diseases: atherosclerosis study group. Circulation 1984: 70(1): 155–205A
- Mahley RW, Innerarity TL, Rall SC Jr, et al. Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984: 25(12): 1277–94
- Brewer HB Jr, Sprecher DL, Gregg RE, et al. Risk factore for the development of premature cardiovascular disease. Adv Exp Med Biol 1985: 183: 27–36
- Maciejko JJ, Holmes DR, Kottke BA, et al. Apolipoprotein A-I as a marker of angiographically assesseds coronary artery disease. N Engl J Med 1983: 309(7): 385–9
- Goldman L, Cook EF. The decline in ischemic heart disease mortality” rates: an analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med 1984: 101 (6): 825–36
- Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. 1. Reduction in incidence of coronary heart disease. JAMA 1984: 251 (3): 351–64
- Merode TV, Hick P, Hocks AP, et al. Serum HDL/total cholesterol ratio and blood pressure in asymptomatic atheroscleroticlesions of the cervical carotid arteries in men. Stroke 1985:16(1): 34–8
- Keys A, Karvonen MJ, Punsar S, et al. HDL serum cholesterol and 24-year mortality of men in Finland. Int J Epidemiol 1984: 13(4): 428–35
- Green MS, Heiss G, Rifkind BM, et al. The ratio of plasma high-density lipoprotein cholesterol to total and low-density lipoprotein cholesterol: age-related changes and race and sex differences in selected North American populations. The Lipid Research Clinics Program Prevalence Study. Circulation 1985: 72(1): 93–104
- Lowering blood cholesterol to prevent heart disease. Nat Inst Health Consensus Dev Conf Consensus Statement 1985:5(7): 27
- Rhoads GG, Dahlen G, Berg K, et al. Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986:256(18): 2540–4
- Schmidt SB, Wasserman AG, Muesing RA, et al. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis. Am J Cardiol 1985: 55(13Pt1): 1459–62
- Superko HR, Bachorlk PS, Wood PD. High-density lipoprotein cholesterol measurements: a help or hindrance in practical clinical medicine? JAMA 1986: 256(19): 2714–7
- Arntzenius AC, Kromhont D, Barth JD, et al. Diet, lipoproteins, and the progression of coronaiy atherosclerosis: the Leiden Intervention Trial. N Engl J Med 1985:312(13): 805–11
- Sacks FM, Handysides GH, Marais GE. et al. Effects of low-fat diet on plasma lipoprotein levels. Arch Intern Med 1986: 146(8): 1573–7
- Tzagonrnis M. Triglycerides in clinical medicine: a review. Am J Clin Nutr 1978: 31(8): 1437–52
- Gonen B, Patsch W, Kuisk I et al. Altered HDL subclasses in endogenous hypertriglyceridemia are not affected by weight reduction. Metabolism 1985: 34(5): 494–501
- Kane JP, Malloy MJ, Tun P, et al. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen. N Engl J Med 1981:304(5): 251–8